BACKGROUND - The aim of this study was to validate the Quality of Life in Adult Cancer Survivors (QLACS) in short-term Spanish cancer survivor's patients.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
METHODS - Patients with breast, colorectal or prostate cancer that had finished their initial cancer treatment 3 years before the beginning of this study completed QLACS, WHOQOL, Short Form-36, Hospital Anxiety and Depression Scale, EORTC-QLQ-BR23 and EQ-5D.
Cultural adaptation was made based on established guidelines. Reliability was evaluated using internal consistency and test-retest. Convergent validity was studied by mean of Pearson's correlation coefficient. Structural validity was determined by a second-order confirmatory factor analysis (CFA) and Rasch analysis was used to assess the unidimensionality of the Generic and Cancer-specific scales.
RESULTS - Cronbach's alpha were above 0. 7 in all domains and summary scales. Test-retest coefficients were 0. 88 for Generic and 0. 82 for Cancer-specific summary scales. QLACS generic summary scale was correlated with other generic criterion measures, SF-36 MCS (r = - 0. 74) and EQ-VAS (r = - 0. 63). QLACS cancer-specific scale had lower values with the same constructs. CFA provided satisfactory fit indices in all cases. The RMSEA value was 0. 061 and CFI and TLI values were 0. 929 and 0. 925, respectively. All factor loadings were higher than 0. 40 and statistically significant (P < 0. 001). Generic summary scale had eight misfitting items. In the remaining 20 items, the unidimensionality was supported. Cancer Specific summary scale showed four misfitting items, the remaining showed unidimensionality.
CONCLUSIONS - The findings support the validity and reliability of QLACS questionnaire to be used in short-term cancer survivors.
Health and quality of life outcomes. 2015 Nov 16*** epublish ***
Antonio Escobar, Maria Del Mar Trujillo-Martín, Antonio Rueda, Elisabeth Pérez-Ruiz, Nancy E Avis, Amaia Bilbao
Unidad de Investigación, Hospital Universitario Basurto, Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Avenida Montevideo, 18, 48013, Bilbao, Bizkaia, Spain. Servicio de Evaluación y Planificación. Dirección del Servicio Canario de la Salud. Fundación Canaria de Investigación Sanitaria (FUNCANIS), Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Camino Candelaria, 44. C. S. San Isidro-El Chorrillo, 38109, El Rosario, Tenerife, Spain. Área de Oncología, Hospital Costa del Sol, Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Autovía A-7, Km 187, 29603, Marbella, Málaga, Spain. Servicio de Oncología Médica, Hospital Costa del Sol, Autovía A-7, Km 187, 29603, Marbella, Málaga, Spain. Division of Public Health Sciences, Department of Social Sciences and Health Policy, Medical Center Boulevard Wake Forest School of Medicine, Winston-Salem, NC, 27157-1063, USA. Unidad de Investigación, Hospital Universitario Basurto, Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Avenida Montevideo, 18, 48013, Bilbao, Bizkaia, Spain.